(Q46152808)

English

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL).

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL). (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

John J. P. Kastelein

4

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

author name string

Ingar Holme

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Nilo B Cater

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Ole Faergeman

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Anders G Olsson

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Matti J Tikkanen

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Mogens Lytken Larsen

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Christina Lindahl

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Terje R Pedersen

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Annals of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

40

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

456-464

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

1 reference

https://api.crossref.org/works/10.1080%2F07853890801964955

21 January 2018

Identifiers

10.1080/07853890801964955

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160529

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46152808&oldid=1556013602"